Clinical Trial Update: Aliskiren vs Hydrochlorothiazide in Hypertensive Type II Diabetic Patients on Resistance Arteries [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing aliskiren versus hydrochlorothiazide in patients with hypertension and type 2 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Aliskiren (Aliskiren)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Hypertension, Diabetes | Phase 2 | Status: WITHDRAWN